LifeMD, Inc. (NASDAQ:LFMD) Receives Average Rating of “Moderate Buy” from Analysts

LifeMD, Inc. (NASDAQ:LFMD) has been given a consensus recommendation of “Moderate Buy” by the nine analysts that are covering the stock, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell rating, two have assigned a hold rating, five have assigned a buy rating and one has assigned a strong buy rating to the company. The average 12 month price target among brokers that have covered the stock in the last year is $13.1667.

Several analysts have recently issued reports on LFMD shares. Zacks Research raised LifeMD from a “strong sell” rating to a “hold” rating in a report on Friday, September 5th. Wall Street Zen cut shares of LifeMD from a “buy” rating to a “hold” rating in a research report on Saturday, August 2nd. KeyCorp decreased their price target on shares of LifeMD from $14.00 to $12.00 and set an “overweight” rating on the stock in a research note on Wednesday, August 6th. Lake Street Capital lowered their price objective on shares of LifeMD from $18.00 to $14.00 and set a “buy” rating for the company in a research report on Wednesday, August 6th. Finally, Weiss Ratings reissued a “sell (d-)” rating on shares of LifeMD in a research note on Wednesday, October 8th.

LifeMD Trading Down 1.4%

Shares of LFMD stock opened at $5.06 on Wednesday. The company has a current ratio of 0.77, a quick ratio of 0.72 and a debt-to-equity ratio of 9.21. The stock has a market capitalization of $239.95 million, a price-to-earnings ratio of -24.10 and a beta of 1.57. LifeMD has a 12-month low of $4.13 and a 12-month high of $15.84. The stock’s 50-day moving average price is $6.16 and its 200-day moving average price is $8.78.

Insider Transactions at LifeMD

In other news, insider Nicholas P. Alvarez sold 75,000 shares of the firm’s stock in a transaction that occurred on Wednesday, September 10th. The stock was sold at an average price of $5.92, for a total value of $444,000.00. Following the completion of the sale, the insider directly owned 605,000 shares of the company’s stock, valued at $3,581,600. This trade represents a 11.03% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. 18.40% of the stock is currently owned by company insiders.

Institutional Investors Weigh In On LifeMD

Several hedge funds and other institutional investors have recently modified their holdings of LFMD. CWM LLC raised its holdings in shares of LifeMD by 17.5% in the first quarter. CWM LLC now owns 9,050 shares of the company’s stock valued at $49,000 after acquiring an additional 1,351 shares in the last quarter. Nisa Investment Advisors LLC raised its holdings in shares of LifeMD by 148.5% in the 2nd quarter. Nisa Investment Advisors LLC now owns 3,656 shares of the company’s stock valued at $50,000 after purchasing an additional 2,185 shares in the last quarter. Tower Research Capital LLC TRC lifted its position in shares of LifeMD by 110.4% in the 2nd quarter. Tower Research Capital LLC TRC now owns 4,674 shares of the company’s stock worth $64,000 after purchasing an additional 2,452 shares during the period. King Wealth Management Group bought a new position in shares of LifeMD during the third quarter valued at approximately $68,000. Finally, Caitong International Asset Management Co. Ltd increased its holdings in LifeMD by 1,004.9% during the second quarter. Caitong International Asset Management Co. Ltd now owns 5,171 shares of the company’s stock valued at $70,000 after buying an additional 4,703 shares during the period. 35.52% of the stock is currently owned by hedge funds and other institutional investors.

About LifeMD

LifeMD, Inc operates as a direct-to-patient telehealth company that connects consumers to healthcare professionals for medical care in the United States. The company offers telehealth platform comprising RexMD, a men's telehealth brand that provides access to virtual medical treatment for a variety of men's health needs from licensed physician; ShapiroMD that provides virtual medical treatment, prescription medications, patented doctor formulated OTC products, topical compounded medications, and medical devices treating male and female hair loss; NavaMD, a female-oriented tele-dermatology that offers virtual medical treatment from dermatologists and other providers; and prescription oral and compounded topical medications to treat aging and acne; and Cleared which provides personalized treatments for allergy, asthma and immunology, including in-home tests for both environmental and food allergies, prescriptions for allergies and asthma and immunotherapies for treating chronic allergies.